Abiopharma

News list

Yednock Ted 🟡 adjusted position in 0 shares (1 derivative) of Annexon, Inc. (ANNX) at $1.85 Transaction Date: Jun 11, 2026 | Filing ID: 000004

Full text

News bot June 15, 2026, 8:15 p.m.
🔍 Yednock Ted (Executive)

Company: Annexon, Inc. (ANNX)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 30,646
- Total shares sold: 30,646
Detailed Transactions and Holdings:
- Acquired 30,646 shares of Common Stock at $1.8501 per share (Direct)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 184,807.00 | transaction_form_type: 4
- Sold 30,646 shares of Stock Option (Right to Buy) at $1.8501 per share (Derivative)
  Date: 2026-06-11 | Code: M | Expires: 2026-08-11 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The shares subject to the option are fully vested and exercisable.